GRI 주가 차트
GRI 주가 예측
GRI Bio Inc
$2.26
-0.87%
$-0.02
종가: May 13, 16:00:00 GMT-4
$2.32
2.85%
$0.06
애프터마켓: May 13, 20:00:00 GMT-4
뒤로
GRI Bio Inc (GRI) 주가 예측
주요 통계
이전 종가
$2.28
시가
$2.24
일일 범위
$2.23 - $2.32
52주 범위
$2.1 - $80.36
거래량
8.6K
평균 거래량
286.7K
배당수익률
--
EPS(TTM)
-91.65
시가총액
$3.3M
GRI란 무엇인가요?
GRI Bio, Inc. engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. The company is headquartered in La Jolla, California and currently employs 4 full-time employees. The company went IPO on 2021-02-10. The Company’s therapies are designed to target the activity of Natural Killer T (NKT) cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis. Its lead program, GRI-0621, is an inhibitor of iNKT cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The firm is also developing a pipeline of novel type II diverse NKT agonists for the treatment of systemic lupus erythematosus. Its product candidate portfolio also includes GRI-0803 and a proprietary library of more than 500 compounds. The company is developing GRI-0803 for the treatment of autoimmune disorders, with much of its preclinical work in systemic lupus erythematosus disease (SLE) and multiple sclerosis (MS).
